WHO Classification of Tumours: Digestive System Tumours 5th ed.

WHO Classification of Tumours: Digestive System Tumours 5th ed.

Descripcion del producto

  • 2019. World Health Organization. 5th ed.  Softbound. ‎ 635 pages. 
  • Digestive System Tumours is the first volume in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education.
  • 1 Introduction to tumours of the digestive system 13
  • General introduction 14
  • Classification of neuroendocrine neoplasms
  • of the digestive system 16
  • TNM staging of well-differentiated neuroendocrine tumours
  • of the gastrointestinal tract 20
  • 2 Tumours of the oesophagus 23
  • WHO classification of tumours of the oesophagus 24
  • TNM staging of tumours of the oesophagus 25
  • Introduction 28
  • Benign epithelial tumours and precursors
  • Squamous papilloma 30
  • Barrett dysplasia 32
  • Squamous dysplasia 36
  • Malignant epithelial tumours
  • Adenocarcinoma of the oesophagus and
  • oesophagogastric junction NOS 38
  • Adenoid cystic carcinoma 44
  • Adenosquamous and mucoepidermoid carcinomas 46
  • Squamous cell carcinoma NOS 48
  • Undifferentiated carcinoma 54
  • Neuroendocrine neoplasms 56
  • 3 Tumours of the stomach 59
  • WHO classification of tumours of the stomach 60
  • TNM staging of carcinomas of the stomach 61
  • Introduction 64
  • Gastritis and metaplasia: precursors of gastric neoplasms 65
  • Benign epithelial tumours and precursors
  • Fundic gland polyps 67
  • Hyperplastic polyps 69
  • Dysplasia 71
  • Intestinal-type adenoma 76
  • Foveolar-type adenoma 79
  • Pyloric gland adenoma 81
  • Oxyntic gland adenoma 83
  • Malignant epithelial tumours
  • Adenocarcinoma 85
  • Squamous cell carcinoma 96
  • Adenosquamous carcinoma 98
  • Undifferentiated carcinoma 100
  • Gastroblastoma 102
  • Neuroendocrine neoplasms 104
  • 4 Tumours of the small intestine and ampulla 111
  • WHO classification of tumours of the small intestine
  • and ampulla 112
  • TNM staging of carcinomas of the small intestine 113
  • TNM staging of carcinomas of the ampulla of Vater 114
  • Introduction 116
  • Benign epithelial tumours and precursors
  • Non-ampullary adenoma 118
  • Ampullary adenoma 121
  • Malignant epithelial tumours
  • Non-ampullary adenocarcinoma 124
  • Ampullary adenocarcinoma 127
  • Neuroendocrine neoplasms 131
  • 5 Tumours of the appendix 135
  • WHO classification of tumours of the appendix 136
  • TNM staging of adenocarcinomas of the appendix 137
  • Introduction 140
  • Epithelial tumours
  • Serrated lesions and polyps 141
  • Mucinous neoplasm 144
  • Adenocarcinoma 147
  • Goblet cell adenocarcinoma 149
  • Neuroendocrine neoplasms 152
  • 6 Tumours of the colon and rectum 157
  • WHO classification of tumours of the colon and rectum 158
  • TNM staging of carcinomas of the colon and rectum 159
  • Introduction 162
  • Benign epithelial tumours and precursors
  • Serrated lesions and polyps 163
  • Conventional adenoma 170
  • Inflammatory bowel disease–associated dysplasia 174
  • Malignant epithelial tumours
  • Adenocarcinoma 177
  • Neuroendocrine neoplasms 188
  • 7 Tumours of the anal canal 193
  • WHO classification of tumours of the anal canal 194
  • TNM staging of tumours of the anal canal and perianal skin 195
  • Introduction 196
  • Benign epithelial tumours and precursors
  • Inflammatory cloacogenic polyp 198
  • Condyloma 200
  • Squamous dysplasia (intraepithelial neoplasia) 202
  • Malignant epithelial tumours
  • Squamous cell carcinoma 205
  • Adenocarcinoma 208
  • Neuroendocrine neoplasms 212
  • 8 Tumours of the liver and intrahepatic bile ducts 215
  • WHO classification of tumours of the liver and
  • intrahepatic bile ducts 216
  • TNM staging of tumours of the liver 217
  • TNM staging of tumours of the intrahepatic bile ducts 218
  • Introduction 220
  • Benign hepatocellular tumours
  • Focal nodular hyperplasia of the liver 221
  • Hepatocellular adenoma 224
  • Malignant hepatocellular tumours and precursors
  • Hepatocellular carcinoma 229
  • Hepatoblastoma 240
  • Benign biliary tumours and precursors
  • Bile duct adenoma 245
  • Biliary adenofibroma 248
  • Mucinous cystic neoplasm of the liver and biliary system 250
  • Biliary intraepithelial neoplasia (see Ch. 9)
  • Intraductal papillary neoplasm of the bile ducts
  • (see Ch. 9)
  • Malignant biliary tumours
  • Intrahepatic cholangiocarcinoma 254
  • Combined hepatocellular-cholangiocarcinoma and
  • undifferentiated primary liver carcinoma 260
  • Hepatic neuroendocrine neoplasms 263
  • 9 Tumours of the gallbladder and extrahepatic bile ducts 265
  • WHO classification of tumours of the gallbladder and
  • extrahepatic bile ducts 266
  • TNM staging of tumours of the gallbladder 267
  • TNM staging of tumours of the perihilar bile ducts 268
  • TNM staging of tumours of the distal extrahepatic bile duct 269
  • Introduction 270
  • Benign epithelial tumours and precursors
  • Pyloric gland adenoma of the gallbladder 271
  • Biliary intraepithelial neoplasia 273
  • Intracholecystic papillary neoplasm 276
  • Intraductal papillary neoplasm of the bile ducts 279
  • Mucinous cystic neoplasm of the liver and biliary system
  • (see Ch. 8)
  • Malignant epithelial tumours
  • Carcinoma of the gallbladder 283
  • Carcinoma of the extrahepatic bile ducts 289
  • Neuroendocrine neoplasms of the
  • gallbladder and bile ducts 292
  • 10 Tumours of the pancreas 295
  • WHO classification of tumours of the pancreas 296
  • TNM staging of carcinomas of the pancreas 297
  • Introduction 298
  • Benign epithelial tumours and precursors
  • Acinar cystic transformation 300
  • Serous neoplasms 303
  • Intraepithelial neoplasia 307
  • Intraductal papillary mucinous neoplasm 310
  • Intraductal oncocytic papillary neoplasm 315
  • Intraductal tubulopapillary neoplasm 317
  • Mucinous cystic neoplasm 319
  • Malignant epithelial tumours
  • Ductal adenocarcinoma 322
  • Acinar cell carcinoma 333
  • Pancreatoblastoma 337
  • Solid pseudopapillary neoplasm 340
  • Neuroendocrine neoplasms
  • Introduction 343
  • Non-functioning pancreatic neuroendocrine tumours 347
  • Functioning neuroendocrine tumours
  • Insulinoma 353
  • Gastrinoma 355
  • VIPoma 357
  • Glucagonoma 359
  • Somatostatinoma 361
  • ACTH-producing neuroendocrine tumour 363
  • Serotonin-producing neuroendocrine tumour 365
  • Neuroendocrine carcinoma 367
  • MiNENs 370
  • 11 Haematolymphoid tumours of the digestive system 373
  • WHO classification of haematolymphoid tumours
  • of the digestive system 374
  • Introduction 376
  • Site-specific haematolymphoid tumours
  • Extranodal marginal zone lymphoma of mucosa-
  • associated lymphoid tissue (MALT lymphoma) 378
  • Duodenal-type follicular lymphoma 383
  • Enteropathy-associated T-cell lymphoma 386
  • Monomorphic epitheliotropic intestinal T-cell lymphoma 390
  • Intestinal T-cell lymphoma NOS 393
  • Indolent T-cell lymphoproliferative disorder of the GI tract 395
  • Hepatosplenic T-cell lymphoma 397
  • EBV+ inflammatory follicular dendritic cell sarcoma 399
  • Haematolymphoid tumours occurring with some frequency
  • in the digestive system
  • Diffuse large B-cell lymphoma 402
  • Follicular lymphoma 406
  • Mantle cell lymphoma 408
  • Burkitt lymphoma 411
  • Plasmablastic lymphoma 415
  • Posttransplant lymphoproliferative disorders 417
  • Extranodal NK/T-cell lymphoma 420
  • Systemic mastocytosis 423
  • Langerhans cell histiocytosis 426
  • Follicular dendritic cell sarcoma 428
  • Histiocytic sarcoma 430
  • 12 Mesenchymal tumours of the digestive system 433
  • WHO classification of mesenchymal tumours
  • of the digestive system 434
  • TNM staging of gastrointestinal stromal tumours 435
  • Introduction 436
  • Gastrointestinal stromal tumour 439
  • Adipose tissue and (myo)fibroblastic tumours
  • Inflammatory myofibroblastic tumour 444
  • Desmoid fibromatosis 446
  • Solitary fibrous tumour 448
  • Lipoma 450
  • Inflammatory fibroid polyp 452
  • Plexiform fibromyxoma 454
  • Smooth muscle and skeletal muscle tumours
  • Leiomyoma 456
  • Leiomyosarcoma 458
  • Rhabdomyosarcoma 460
  • Vascular and perivascular tumours
  • Haemangioma 462
  • Epithelioid haemangioendothelioma 466
  • Kaposi sarcoma 468
  • Angiosarcoma 471
  • Glomus tumour 473
  • Lymphangioma and lymphangiomatosis 475
  • Neural tumours
  • Schwannoma 477
  • Granular cell tumour 479
  • Perineurioma 481
  • Ganglioneuroma and ganglioneuromatosis 483
  • Tumours of uncertain differentiation
  • PEComa, including angiomyolipoma 485
  • Mesenchymal hamartoma of the liver 488
  • Calcifying nested stromal-epithelial tumour of the liver 490
  • Synovial sarcoma 492
  • Gastrointestinal clear cell sarcoma / malignant
  • gastrointestinal neuroectodermal tumour 494
  • Embryonal sarcoma of the liver 497
  • 13 Other tumours of the digestive system 499
  • WHO classification of other tumours of the digestive system 500
  • Mucosal melanoma 502
  • Germ cell tumours 504
  • Metastases 506
  • 14 Genetic tumour syndromes of the digestive system 511
  • Introduction 512
  • Lynch syndrome 515
  • Familial adenomatous polyposis 1 522
  • GAPPS and other fundic gland polyposes 526
  • Other adenomatous polyposes 529
  • Serrated polyposis 532
  • Hereditary diffuse gastric cancer 535
  • Familial pancreatic cancer 539
  • Juvenile polyposis syndrome 542
  • Peutz–Jeghers syndrome 545
  • Cowden syndrome 547
  • Other genetic tumour syndromes 550
  • Contributors 551
  • Declaration of interests 557
  • IARC/WHO Committee for ICD-O 558
  • Sources 559
  • References 567
  • Subject index 625
  • Previous volumes in the series 63